Annual EBIT:
-$175.62M-$136.63M(-350.44%)Summary
- As of today, SLNO annual earnings before interest & taxes is -$175.62 million, with the most recent change of -$136.63 million (-350.44%) on December 31, 2024.
- During the last 3 years, SLNO annual EBIT has fallen by -$143.36 million (-444.40%).
- SLNO annual EBIT is now -20634.24% below its all-time high of -$847.00 thousand, reached on December 31, 2013.
Performance
SLNO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$3.33M+$39.08M(+92.14%)Summary
- As of today, SLNO quarterly earnings before interest & taxes is -$3.33 million, with the most recent change of +$39.08 million (+92.14%) on June 30, 2025.
- Over the past year, SLNO quarterly EBIT has increased by +$18.52 million (+84.75%).
- SLNO quarterly EBIT is now -270.11% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$175.06M+$18.52M(+9.57%)Summary
- As of today, SLNO TTM earnings before interest & taxes is -$175.06 million, with the most recent change of +$18.52 million (+9.57%) on June 30, 2025.
- Over the past year, SLNO TTM EBIT has dropped by -$109.30 million (-166.21%).
- SLNO TTM EBIT is now -9037.46% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLNO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -350.4% | +84.8% | -166.2% |
| 3Y3 Years | -444.4% | +45.9% | -551.8% |
| 5Y5 Years | -657.1% | +60.1% | -464.5% |
SLNO EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -629.7% | at low | at high | +95.8% | -627.4% | +9.6% |
| 5Y | 5-Year | -657.1% | at low | at high | +95.8% | -627.4% | +9.6% |
| All-Time | All-Time | >-9999.0% | at low | -270.1% | +95.8% | -9037.5% | +9.6% |
SLNO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$3.33M(+92.1%) | -$175.06M(+9.6%) |
| Mar 2025 | - | -$42.41M(+15.1%) | -$193.58M(-12.2%) |
| Dec 2024 | -$175.62M(-350.4%) | -$49.98M(+37.0%) | -$172.57M(-27.1%) |
| Sep 2024 | - | -$79.33M(-263.0%) | -$135.73M(-106.4%) |
| Jun 2024 | - | -$21.85M(-2.1%) | -$65.76M(-25.9%) |
| Mar 2024 | - | -$21.40M(-62.8%) | -$52.22M(-33.9%) |
| Dec 2023 | -$38.99M(-62.0%) | -$13.15M(-40.4%) | -$38.99M(-25.7%) |
| Sep 2023 | - | -$9.36M(-12.6%) | -$31.01M(-11.7%) |
| Jun 2023 | - | -$8.31M(-1.7%) | -$27.75M(-8.4%) |
| Mar 2023 | - | -$8.17M(-58.0%) | -$25.61M(-6.4%) |
| Dec 2022 | -$24.07M(+25.4%) | -$5.17M(+15.3%) | -$24.07M(+4.6%) |
| Sep 2022 | - | -$6.10M(+1.0%) | -$25.23M(+6.1%) |
| Jun 2022 | - | -$6.16M(+7.1%) | -$26.86M(+6.6%) |
| Mar 2022 | - | -$6.63M(-4.8%) | -$28.75M(+10.9%) |
| Dec 2021 | -$32.26M(-1.0%) | -$6.33M(+18.2%) | -$32.26M(+4.4%) |
| Sep 2021 | - | -$7.74M(+3.9%) | -$33.75M(-2.0%) |
| Jun 2021 | - | -$8.05M(+20.6%) | -$33.09M(+0.9%) |
| Mar 2021 | - | -$10.14M(-29.8%) | -$33.39M(-4.5%) |
| Dec 2020 | -$31.95M(-37.7%) | -$7.82M(-10.4%) | -$31.95M(-3.0%) |
| Sep 2020 | - | -$7.08M(+15.2%) | -$31.01M(-3.3%) |
| Jun 2020 | - | -$8.35M(+4.0%) | -$30.03M(-10.7%) |
| Mar 2020 | - | -$8.70M(-26.4%) | -$27.12M(-16.9%) |
| Dec 2019 | -$23.20M | -$6.88M(-12.7%) | -$23.20M(-16.7%) |
| Sep 2019 | - | -$6.11M(-12.2%) | -$19.87M(-14.1%) |
| Jun 2019 | - | -$5.44M(-14.0%) | -$17.42M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$4.77M(-34.2%) | -$15.46M(-12.6%) |
| Dec 2018 | -$13.73M(-6.9%) | -$3.56M(+2.5%) | -$13.73M(+14.5%) |
| Sep 2018 | - | -$3.65M(-4.9%) | -$16.06M(-6.8%) |
| Jun 2018 | - | -$3.48M(-14.2%) | -$15.04M(-3.5%) |
| Mar 2018 | - | -$3.05M(+48.2%) | -$14.53M(-13.0%) |
| Dec 2017 | -$12.85M(-54.4%) | -$5.88M(-123.5%) | -$12.85M(-46.0%) |
| Sep 2017 | - | -$2.63M(+11.4%) | -$8.81M(-8.1%) |
| Jun 2017 | - | -$2.97M(-116.2%) | -$8.14M(-9.0%) |
| Mar 2017 | - | -$1.37M(+25.1%) | -$7.47M(+27.9%) |
| Dec 2016 | -$8.32M(+31.5%) | -$1.83M(+6.9%) | -$10.36M(-35.9%) |
| Sep 2016 | - | -$1.97M(+14.2%) | -$7.62M(+14.8%) |
| Jun 2016 | - | -$2.29M(+46.2%) | -$8.95M(+7.7%) |
| Mar 2016 | - | -$4.26M(-571.9%) | -$9.70M(-23.4%) |
| Dec 2015 | -$12.16M(-33.5%) | $903.30K(+127.4%) | -$7.86M(+46.0%) |
| Sep 2015 | - | -$3.29M(-8.2%) | -$14.56M(-15.7%) |
| Jun 2015 | - | -$3.04M(-25.5%) | -$12.59M(-16.0%) |
| Mar 2015 | - | -$2.43M(+58.1%) | -$10.85M(-22.3%) |
| Dec 2014 | -$9.11M(-975.2%) | -$5.79M(-337.9%) | -$8.87M(-137.1%) |
| Sep 2014 | - | -$1.32M(-1.2%) | -$3.74M(-54.7%) |
| Jun 2014 | - | -$1.31M(-193.0%) | -$2.42M(-4.5%) |
| Mar 2014 | - | -$446.00K(+32.8%) | -$2.31M(-2591.3%) |
| Dec 2013 | -$847.00K(+76.6%) | -$664.00K(+44.8%) | $92.80K(-87.7%) |
| Jun 2013 | - | -$1.20M(-161.4%) | $756.80K(-61.4%) |
| Mar 2013 | - | $1.96M | $1.96M |
| Dec 2012 | -$3.62M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual EBIT year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Soleno Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM EBIT year-on-year change?
What is Soleno Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of SLNO is -$175.62M
What is the all-time high annual EBIT for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$847.00K
What is Soleno Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, SLNO annual earnings before interest & taxes has changed by -$136.63M (-350.44%)
What is Soleno Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SLNO is -$3.33M
What is the all-time high quarterly EBIT for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $1.96M
What is Soleno Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, SLNO quarterly earnings before interest & taxes has changed by +$18.52M (+84.75%)
What is Soleno Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SLNO is -$175.06M
What is the all-time high TTM EBIT for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $1.96M
What is Soleno Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, SLNO TTM earnings before interest & taxes has changed by -$109.30M (-166.21%)